TW201742641A - Blood separation system - Google Patents

Blood separation system Download PDF

Info

Publication number
TW201742641A
TW201742641A TW106113638A TW106113638A TW201742641A TW 201742641 A TW201742641 A TW 201742641A TW 106113638 A TW106113638 A TW 106113638A TW 106113638 A TW106113638 A TW 106113638A TW 201742641 A TW201742641 A TW 201742641A
Authority
TW
Taiwan
Prior art keywords
pump
container
blood
fluid
separation device
Prior art date
Application number
TW106113638A
Other languages
Chinese (zh)
Inventor
韋德 N 理查德森
殷廷 朱
Original Assignee
幹細胞生物科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 幹細胞生物科技股份有限公司 filed Critical 幹細胞生物科技股份有限公司
Publication of TW201742641A publication Critical patent/TW201742641A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A61M1/3695Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging with sedimentation by gravity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0413Blood
    • A61M2202/0429Red blood cells; Erythrocytes
    • A61M2202/0437Blood stem cells

Abstract

A separation system comprising a blood separation device containing a controller, a red-blood-cell (RBC) detection module, and a pump driver; and a cartridge configured to be reversibly attached to the blood separation device, the cartridge including: (i) a first container configured to contain a blood sample, wherein the first container includes a first opening; (ii) a tubing in fluid flow communication with the first opening; (iii) a pump in fluid flow communication with the tubing, wherein the pump is configured to move a fluid from the first container to the pump and to contain a fluid; and (iv) a check valve mounted to the tubing, wherein the check valve is configured to allow a fluid to flow from the first container to the pump and to not allow a fluid to flow from the pump to the first container.

Description

血液分離系統Blood separation system

本案揭露內容係有關於血液分離系統(blood separation system)。The disclosure of this case relates to the blood separation system.

發明背景 幹細胞(stem cells)具有自我更新(self-renew)的能力以生成更多的幹細胞且亦可成為幾乎任何類型的特化細胞(specialized cells)。幹細胞研究對於瞭解人類發展(human development)是有用的,而且是當代生物學的最吸引人的領域之一。因此,幹細胞對於未來的醫學科學提供了令人振奮的希望。BACKGROUND OF THE INVENTION Stem cells have the ability to self-renew to generate more stem cells and can also become almost any type of specialized cells. Stem cell research is useful for understanding human development and is one of the most attractive areas of contemporary biology. Therefore, stem cells provide exciting hope for future medical science.

發明概要 在一個方面中,被描述於此的是一種分離系統(separation system),其包括:一含有一控制器(controller)、一紅血球(RBC)偵測模組(detection module)以及一泵驅動器(pump driver)的血液分離裝置(blood separation device);以及一被配置成要被可逆地附接至(reversibly attached to)該血液分離裝置的匣(cartridge)。該匣包含:(i)一個第一容器(first container)被配置成用以含有一血液樣品(blood sample),其中該第一容器包含一第一開口(first opening);(ii)一配管(tubing)與該第一開口呈流體流動連通(in fluid flow communication);(iii)一泵(pump)與該配管呈流體流動連通,其中該泵被配置成用以將一流體從該第一容器移動至該泵以及用以含有一流體;以及(iv)一被安裝至該配管的止回閥(check valve),其中該止回閥被配置成用以容許一流體從該第一容器流動至該泵而且不容許一流體從該泵流動至該第一容器。在一個具體例中,該RBC偵測模組被配置成用以(i)偵測位在一位處於該第一開口和該泵之間的偵測點(detection point)之處的該配管內的紅血球,以及(ii)當紅血球被偵測到位在該配管之內時,產生一要被傳送至該控制器的第一信號(first signal)。該RBC偵測模組可被配置成用以發射一光(emit a light)至該偵測點以及偵測明確地表示紅血球存在於流體中的該光之反射(reflection)、散射(scattering)、吸收(absorption)或螢光(fluorescence)。SUMMARY OF THE INVENTION In one aspect, described herein is a separation system comprising: a controller, a red blood cell (RBC) detection module, and a pump driver (pump driver) a blood separation device; and a cartridge configured to be reversibly attached to the blood separation device. The crucible comprises: (i) a first container configured to contain a blood sample, wherein the first container comprises a first opening; (ii) a pipe ( Tubing) in fluid flow communication with the first opening; (iii) a pump in fluid flow communication with the pipe, wherein the pump is configured to draw a fluid from the first container Moving to the pump and for containing a fluid; and (iv) a check valve mounted to the pipe, wherein the check valve is configured to allow a fluid to flow from the first container to The pump also does not allow a fluid to flow from the pump to the first container. In a specific example, the RBC detection module is configured to (i) detect a position in a pipe at a detection point between the first opening and the pump. The red blood cell, and (ii) when the red blood cell is detected within the pipe, produces a first signal to be transmitted to the controller. The RBC detection module can be configured to emit a light to the detection point and detect reflection, scattering, and light that clearly indicates that the red blood cell is present in the fluid. Absorption or fluorescence.

該控制器可被配置成用以接收來自該RBC偵測模組的該第一信號,以及在接收該第一信號之後產生一要被傳送至該泵驅動器的第二信號(second signal)。該泵驅動器可被配置成用以接收該第二信號,以及在接收該第二信號之後驅動該泵來停止將一流體從該第一容器移動至該泵。該血液分離裝置可進一步包含一溫度感測器(temperature sensor)被配置成用以偵測一位於該第一容器內之流體的溫度以及當該溫度被偵測到之時產生一要被傳送至該控制器的第三信號(third signal)。該血液分離裝置可進一步包含一被耦合至該控制器的冷卻驅動器(cooling driver),以及其中該控制器被配置成在接收該第三信號之後產生並且傳送一第四信號(fourth signal)至該冷卻驅動器。該冷卻驅動器可被配置成用以接收該第四信號以及在接收該第四信號之後驅動冷卻模組(cooling module)以調節(modulate)一位於該第一容器內的流體之溫度。該分離裝置可進一步包含一支持件(holder)被配置成用以按壓該第一容器抵靠著該冷卻模組。該分離裝置亦可包含一散熱座(heatsink)被調適為用以將熱從該冷卻模組傳送至該血液分離裝置的周圍(ambient)。在一個具體例中,該分離裝置被配置成經由無線通信(wireless communication)來與一中央控制單元(central control unit)連通。再者,該分離裝置可被配置成用以將該匣可逆地鎖定在該分離裝置中。The controller can be configured to receive the first signal from the RBC detection module and to generate a second signal to be transmitted to the pump driver after receiving the first signal. The pump driver can be configured to receive the second signal and to drive the pump to stop moving a fluid from the first container to the pump after receiving the second signal. The blood separation device can further include a temperature sensor configured to detect a temperature of a fluid located in the first container and to generate a temperature to be transmitted when the temperature is detected The third signal of the controller. The blood separation device can further include a cooling driver coupled to the controller, and wherein the controller is configured to generate and transmit a fourth signal to the third signal after receiving the third signal Cool the drive. The cooling driver can be configured to receive the fourth signal and, after receiving the fourth signal, drive a cooling module to modulate the temperature of a fluid located within the first container. The separation device can further include a holder configured to press the first container against the cooling module. The separation device can also include a heatsink adapted to transfer heat from the cooling module to the ambient of the blood separation device. In one embodiment, the separation device is configured to communicate with a central control unit via wireless communication. Furthermore, the separation device can be configured to reversibly lock the crucible in the separation device.

在一個具體例中,該匣進一步包含一個第二容器(second container)與該泵呈流體流動連通,其中該泵被調適為用以將一流體從該泵移動至該第二容器。該泵驅動器可被配置為,在接收一來自該控制器的驅動信號(driving signal)之後,驅動該泵俾以將一流體從該泵移動至該第二容器。該匣被調適為,當被定位(fitted)於該血液分離裝置之內時,容許一位於該第一容器之內的血液樣品藉由重力(gravity)而分離成為一上層(upper layer)與一下層(lower layer)。該泵和該第二容器這兩者可以被配置成要被可逆地附接至該匣。In one embodiment, the crucible further includes a second container in fluid flow communication with the pump, wherein the pump is adapted to move a fluid from the pump to the second container. The pump driver can be configured to, after receiving a driving signal from the controller, drive the pump to move a fluid from the pump to the second container. The file is adapted to allow a blood sample located within the first container to be separated into an upper layer and a gravity by gravity when fitted within the blood separation device Lower layer. Both the pump and the second container can be configured to be reversibly attached to the file.

在另一個方面中,一種用以分離一血液樣品的方法被描述於此。舉例而言,該方法可包含本案揭露內容中所述的分離系統之使用。在一個具體例中,該方法包括:提供一包含下列的匣:(i)一個含有一被混合以一種二價陽離子螯合抗凝血劑(divalent cation chelating anticoagulant)的血液樣品之第一容器,其中該第一容器包含一第一開口;(ii)一與該第一開口呈流體流動連通的配管;(iii) 一與該配管呈流體流動連通的泵,其中該泵被可逆地附接至該匣而且被配置成用以將一流體從該第一容器移動至該泵以及用以保持(hold)一流體;以及(iv)一被安裝至該配管的止回閥,其中該止回閥被配置成用以容許一流體從該第一容器流動至該泵而且不容許一流體從該泵流動至該第一容器,其中該匣被配置成要被可逆地附接至一血液分離裝置;將該匣附接至該血液分離裝置而使得該第一容器係處於一直立位置(in an upright position)而且該第一開口係位在該容器的頂部(top);將該第一容器之內的血液樣品冷卻至2℃和12℃;將該血液樣品維持在2℃和12℃之下歷時6至72小時,藉此該血液樣品藉由重力而分離成為一上層與一下層;以及將一部分的上層(a portion of the upper layer)從該第一容器泵送通經該第一開口和該配管而至該泵直至位在該配管內的紅血球在一位處於該第一開口和該泵之間的偵測點之處被偵測到,其中該泵保持該部分的上層(the portion of the upper layer)。在一個具體例中,該匣進一步包含一個第二容器與該泵呈流體流動連通,以及其中該方法進一步包含一個用以將位於該泵內之該部分的上層之一部分(a part of the portion of the upper layer)泵送至該第二容器的步驟,其中該第二容器保持該部分的上層之該部分(the part of the portion of the upper layer)。In another aspect, a method for isolating a blood sample is described herein. For example, the method can include the use of a separation system as described in the disclosure of the present disclosure. In one embodiment, the method comprises: providing a mash comprising: (i) a first container comprising a blood sample mixed with a divalent cation chelating anticoagulant, Wherein the first container comprises a first opening; (ii) a pipe in fluid flow communication with the first opening; (iii) a pump in fluid flow communication with the pipe, wherein the pump is reversibly attached to The raft is also configured to move a fluid from the first container to the pump and to hold a fluid; and (iv) a check valve mounted to the pipe, wherein the check valve Configuring to allow a fluid to flow from the first container to the pump and not allowing a fluid to flow from the pump to the first container, wherein the file is configured to be reversibly attached to a blood separation device; Attaching the file to the blood separation device such that the first container is in an upright position and the first opening is in the top of the container; within the first container Blood sample is cooled to 2 ° C and 12 ° C; maintaining the blood sample at 2 ° C and 12 ° C for 6 to 72 hours, whereby the blood sample is separated by gravity into an upper layer and a lower layer; and a portion of the upper layer (a portion of the upper Pumping a red blood cell from the first container through the first opening and the pipe to the pump until the position in the pipe is at a detection point between the first opening and the pump It is detected that the pump maintains the portion of the upper layer. In one embodiment, the crucible further includes a second container in fluid flow communication with the pump, and wherein the method further includes a portion of the upper portion of the portion of the pump The upper layer is a step of pumping to the second container, wherein the second container holds the part of the portion of the upper layer.

一個或更多的具體例之細節被闡述於附圖以及下面的詳細說明之中。該等具體例的其他特徵、目的和優點將從詳細說明和附圖以及申請專利範圍而變得明顯可見。Details of one or more specific examples are set forth in the accompanying drawings and the detailed description below. Other features, objects, and advantages of the specific embodiments will be apparent from the description and appended claims.

詳細說明 本案揭露內容闡述一種分離系統,它被調適成用以分離一衍生自一個體(諸如一病患)的血液樣品。該系統包含一能夠經由一無線或有線通信網路(wireless or wired communications network)與一中央控制單元[例如,一桌上型或手持式電腦(desktop or hand-held computer)]連通的血液分離裝置,以及一被配置成要被定位於該血液分離裝置之內的匣。DETAILED DESCRIPTION The present disclosure sets forth a separation system that is adapted to separate a blood sample derived from a body, such as a patient. The system includes a blood separation device capable of communicating with a central control unit (eg, a desktop or hand-held computer) via a wireless or wired communications network And a crucible configured to be positioned within the blood separation device.

在本案揭露內容的所有下面段落中被提及的一個諸如一成體幹細胞(somatic stem cell)的細胞之尺寸(Z)可被描述或界定為,但不限於:(1)在細胞生物學領域(field of cell biology)或幹細胞領域(field of stem cells)中,一個細胞的尺寸或代表性長度(representative length)之傳統定義(conventional definition),(2)一個細胞的直徑(diameter),特別是當該細胞基本上是球形的(substantially spherical),(3)一個細胞的長軸(major axis)之長度,特別是當該細胞基本上是橢圓體的(substantially ellipsoidal),(4)當一細胞的形狀具有一近似正方形的形狀(an approximate shape of a square)時,該細胞的寬度(width),(5)當一細胞的形狀具有一近似矩形的形狀(an approximate shape of a rectangle)時,該細胞的長度,或(6)一個細胞之最大橫截面或橫向尺度(cross-sectional or transverse dimension)。該尺寸(Z),其為直徑、長度、寬度或者最大橫斷面或橫向尺寸,可以被決定或測量,但不限於,例如,使用該細胞從一光學顯微鏡(optical microscope)或一諸如掃描電子顯微鏡(scanning electron microscope, SEM)的電子顯微鏡(electron microscope)而得到的影像(image),或使用該細胞從一流式細胞儀(flow cytometer)而得到的數據[例如,二維點、輪廓或密度圖(two-dimensional dot, contour or density plot)]。該細胞從光學顯微鏡或電子顯微鏡所得到的影像可為該細胞的二維(2D)截面或三維(3D)結構。作為一個示範例,該細胞的尺寸(Z)可以是藉由,例如,測量該細胞在一從一光學顯微鏡或一電子顯微鏡(例如SEM)所得到的2D截面影像中的最大橫截面或橫向尺寸,而被獲得。The size (Z) of a cell such as an adult stem cell mentioned in all of the following paragraphs of the disclosure of the present disclosure can be described or defined as, but not limited to: (1) in the field of cell biology (field of cell biology) or field of stem cells, the conventional definition of the size or representative length of a cell, (2) the diameter of a cell, especially When the cell is substantially spherical, (3) the length of a major axis of a cell, especially when the cell is substantially ellipsoidal, (4) when a cell When the shape has an approximate shape of a square, the width of the cell, (5) when the shape of a cell has an approximate shape of a rectangle, The length of the cell, or (6) the cross-sectional or transverse dimension of a cell. The size (Z), which is diameter, length, width or maximum cross-sectional or lateral dimension, can be determined or measured, but is not limited to, for example, using the cells from an optical microscope or a scanning electron. An image obtained by an electron microscope of a scanning electron microscope (SEM), or data obtained from a flow cytometer using the cells [eg, two-dimensional points, contours, or densities) Two-dimensional dot, contour or density plot]. The image obtained by the cell from an optical microscope or an electron microscope may be a two-dimensional (2D) cross section or a three-dimensional (3D) structure of the cell. As an example, the size (Z) of the cell may be, for example, by measuring the maximum cross-sectional or lateral dimension of the cell in a 2D cross-sectional image obtained from an optical microscope or an electron microscope (eg, SEM). And was obtained.

成體幹細胞[亦被稱為成人幹細胞(adult stem cells)]可於一諸如骨髓(bone marrow)、脂肪(fat)或周邊(peripheral)血液的器官或組織內被發現而且擁有所有幹細胞的相同基本特點(same basic characteristics)。一個成體幹細胞是一未特化的(unspecialized)或未分化的(undifferentiated)細胞,它可以分化成為特化的細胞類型。在本案的揭露內容中,成體幹細胞不是胚胎幹細胞(embryonic stem cells);換言之,該等成體幹細胞不是衍生(derived)、取源(sourced)或收穫(harvested)自胚胎(embryos)或胎兒組織(fetal tissue)。Adult stem cells [also known as adult stem cells] can be found in organs or tissues such as bone marrow, fat or peripheral blood and have the same basics of all stem cells. Same basic characteristics. An adult stem cell is an unspecialized or undifferentiated cell that can differentiate into a specialized cell type. In the disclosure of the present disclosure, adult stem cells are not embryonic stem cells; in other words, the adult stem cells are not derived, sourced, or harvested from embryos or fetal tissues. (fetal tissue).

存在有各種不同類型的成體幹細胞,包含全能幹細胞(totipotent stem cells)、萬能幹細胞(pluripotent stem cells)、多能幹細胞(multipotent stem cells)以及前驅幹細胞(progenitor stem cells)[亦被稱為單能幹細胞(unipotent stem cells)]。胚葉樣幹細胞(blastomere-like stem cells, BLSCs)是全能幹細胞或萬能幹細胞。極小胚胎樣幹細胞(very small embryonic-like stem cells, VSELs)是萬能成體幹細胞。SB-1細胞和SB-2細胞是萬能或多能成體幹細胞。There are various types of adult stem cells, including totipotent stem cells, pluripotent stem cells, multipotent stem cells, and progenitor stem cells [also known as single energy Unipotent stem cells]. The blastomere-like stem cells (BLSCs) are pluripotent stem cells or omnipotent stem cells. Very small embryonic-like stem cells (VSELs) are universal adult stem cells. SB-1 cells and SB-2 cells are univalent or multipotent adult stem cells.

參照圖1,一個血液分離系統包含一個被調適成經由一無線或有線通信網路來與一中央控制單元(例如,一桌上型或手持式電腦)連通的血液分離裝置1,以及一個被配置成要被定位於該血液分離裝置1之內的拋棄式匣2。該血液分離系統能夠分離一血液樣品,諸如一個來自一個體的周邊血液樣品。該個體,舉例而言,是一人類[例如,一個孩童(child)、青少年(teenager)、成人(adult)或老年人(elderly person)]或者一動物[例如,一哺乳動物(mammal)]。該血液樣品含有數種細胞,包含一小-細胞部分(small-cell portion)以及一大-細胞部分(large-cell portion)。該血液樣品的小-細胞部分含有,在尺寸[如藉由前面所述之細胞的尺寸(Z)來定義的]上,介於1微米(micrometer)和6微米之間(且更佳為介於2微米和6微米之間)的小細胞。該小-細胞部分含有血小板(platelets)(它們在尺寸上可能是小於6微米)以及小幹細胞。該等小幹細胞[它們每一者具有一個或一個以上的細胞核(a nucleus or nuclei)]含有小成體幹細胞(它們在尺寸上可能是小於或等於6微米),諸如CD349(+)成體幹細胞、Lgr5(+)成體幹細胞、CD66e(+)成體幹細胞(亦即BLSCs)以及VSELs [例如CD133(+)成體幹細胞和CD34(+)成體幹細胞]。該血液樣品的大-細胞部分含有在尺寸[如藉由前面所述之細胞的尺寸(Z)來定義的]上係大於6微米的大細胞,諸如在尺寸係大於6微米的大成體幹細胞以及含有紅血球和白血球(white blood cells)的譜系細胞(lineage cells)。在被處理(processed)之後,該血液樣品分離成為包含一上層[例如一上清液(supernatant liquid)]和一下層的兩個或更多個分開的層。該血液樣品的上層含有該小-細胞部分,而該血液樣品的下層含有該大-細胞部分。該分離系統被調適成用以將該血液樣品的上層和該血液樣品的下層分開。Referring to Figure 1, a blood separation system includes a blood separation device 1 adapted to communicate with a central control unit (e.g., a desktop or handheld computer) via a wireless or wired communication network, and a configured The disposable crucible 2 to be positioned within the blood separation device 1 is formed. The blood separation system is capable of separating a blood sample, such as a peripheral blood sample from a body. The individual, for example, is a human [eg, a child, a teenager, an adult, or an elderly person] or an animal (eg, a mammal). The blood sample contains several cells, including a small-cell portion and a large-cell portion. The small-cell portion of the blood sample contains between 1 micrometer and 6 micrometers (and more preferably in size) as defined by the size (Z) of the cells described above. Small cells between 2 microns and 6 microns). The small-cell fraction contains platelets (which may be less than 6 microns in size) and small stem cells. The small stem cells [each of which have one or more nuclei or nuclei] contain small adult stem cells (which may be less than or equal to 6 microns in size), such as CD349(+) adult stem cells. , Lgr5 (+) adult stem cells, CD66e (+) adult stem cells (ie, BLSCs), and VSELs [eg, CD133 (+) adult stem cells and CD34 (+) adult stem cells]. The large-cell portion of the blood sample contains large cells larger than 6 microns in size, as defined by the size (Z) of the cells described above, such as large adult stem cells having a size system greater than 6 microns and Lineage cells containing red blood cells and white blood cells. After being processed, the blood sample is separated into two or more separate layers comprising an upper layer [e.g., a supernatant liquid] and a lower layer. The upper layer of the blood sample contains the small-cell portion, and the lower layer of the blood sample contains the large-cell portion. The separation system is adapted to separate the upper layer of the blood sample from the lower layer of the blood sample.

該拋棄式匣2,舉例而言,可為一經預先滅菌之單次使用的匣(a pre-sterilized, single-use cartridge),該匣包含一封閉系統(closed system)可讓藉由重力的血液分離於內被進行。參照圖1,該拋棄式匣2含有:(1)一被調適成用以含有該血液樣品的容器,例如一血液容器 (blood container) 23 [例如,一個50 ml、75 ml、100 ml、150 ml、200 ml、250 ml、300 ml、350 ml、400 ml、450 ml或500 ml的血袋(blood bag)],(2)一配管,例如與該血液容器23呈流體流動連通之一系列或系統的管26a、26b和26c,(3)一止回閥,例如一被安裝至該配呈流體流動連通的 管的止回閥27 (例如被配置在該等管26a和26b之間),(4)一被可逆地附接的第一容器 ,例如一與該等管26b和26c或注射器(syringe) 24,以及(5) 一被可逆地附接的第二容器 ,例如一與該管26c呈流體流動連通的注射器25。The disposable 匣2, for example, may be a pre-sterilized single-use cartridge, which includes a closed system for blood by gravity Separation is carried out inside. Referring to Figure 1, the disposable crucible 2 contains: (1) a container adapted to contain the blood sample, such as a blood container 23 [e.g., a 50 ml, 75 ml, 100 ml, 150 Mol, 200 ml, 250 ml, 300 ml, 350 ml, 400 ml, 450 ml or 500 ml blood bag], (2) a tube, for example a series of fluid flow connections with the blood container 23 Or system tubes 26a, 26b and 26c, (3) a check valve, such as a check valve 27 mounted to the pump tube in fluid flow communication (e.g., disposed between the tubes 26a and 26b) (4) a reversibly attached first container , such as a tube 26b and 26c or a syringe 24, and (5) a reversibly attached second container , such as a The tube 26c is in the form of a syringe 25 in fluid flow communication.

該拋棄式匣2被配置成要被可逆地定位至或插入至該血液分離裝置1之內,而使得當該拋棄式匣2被定位至或插入於該血液分離裝置1之內時,該血液容器23係處於一直立位置而且兩個開口23a和23b係位在該血液容器23的頂部。一被使用於血液收集的魯爾鎖緊接頭(Luer lock connector) 29被連接至該血液容器23的開口23a俾以使得該血液樣品經由該魯爾鎖緊接頭29而從該個體流動至該血液容器23之內。該管26a被連接至該血液容器23的開口23b俾以使得該血液樣品的上層經由該血液容器23的開口23b而從該血液容器23流動至該管26a之內。The disposable cartridge 2 is configured to be reversibly positioned or inserted into the blood separation device 1 such that when the disposable cartridge 2 is positioned or inserted within the blood separation device 1, the blood The container 23 is in the upright position and the two openings 23a and 23b are tied to the top of the blood container 23. A Luer lock connector 29 for blood collection is coupled to the opening 23a of the blood container 23 such that the blood sample flows from the individual to the blood via the Luer lock fitting 29 Inside the container 23. The tube 26a is connected to the opening 23b of the blood container 23 such that the upper layer of the blood sample flows from the blood container 23 into the tube 26a via the opening 23b of the blood container 23.

該止回閥27 (連接該管26a和該管26b)可為一容許一流體(例如該血液樣品的上層)僅於一第一方向[亦即一從該血液容器23至該第一注射器24的正向(forward direction)]流動的機械性與單向方向閥(mechanical and one-way directional valve),阻止該流體於一第二方向(亦即一從該第一注射器24至該血液容器23的反向)來流動。處於該第一方向的流體流動開啟該止回閥27,而處於該第二方向的回流(backflow)迫使該止回閥27關閉。因此,該止回閥27 (被安裝在該等管26a和26b之間)被調適成用以使該血液樣品以該第一方向而從該血液容器23依序地經由該管26a、該止回閥27和該管26b來流動至該第一注射器24以及避免該血液樣品以該第二方向而從該第一注射器24流動至該血液容器23。The check valve 27 (connecting the tube 26a and the tube 26b) may allow a fluid (eg, the upper layer of the blood sample) to be in only a first direction [ie, from the blood container 23 to the first syringe 24) a mechanical direction and a one-way directional valve that blocks the fluid in a second direction (ie, from the first syringe 24 to the blood container 23) The reverse) comes to flow. The fluid flow in the first direction opens the check valve 27, and the backflow in the second direction forces the check valve 27 to close. Accordingly, the check valve 27 (mounted between the tubes 26a and 26b) is adapted to sequentially pass the blood sample from the blood container 23 via the tube 26a in the first direction. The return valve 27 and the tube 26b flow to the first syringe 24 and prevent the blood sample from flowing from the first syringe 24 to the blood container 23 in the second direction.

該第一注射器24被調適成用以在重力分離(gravity separation)之後來收集和包含位在該血液容器23中的該血液樣品的上層(包含該血液樣品的該小-細胞部分)。該第一注射器24是一泵,它包含一第一筒(first barrel)24a [例如一個圓柱形管(cylindrical tube)]、一位於該第一筒24a之內的第一柱塞(first plunger) 24b以及一第一開口24c。該第二注射器25被調適成用以含有從該第一注射器24經由該管26c而流動之一部分的該血液樣品的上層。該第二注射器25包含,例如,一第二筒(second barrel) 25a (例如一個圓柱形管)、一被定位於該第二筒25a內的第二柱塞(second plunger) 25b以及一第二開口 (second opening) 25c。該第一注射器24可被調適成用以包含比該第二注射器25要多10%至200% (例如,20%、30%、40%、50%、60%、70%、80%、90%、100%、150%或200%)的流體。舉例而言,該第一注射器24可保持60 ml的流體,而該第二注射器25可保持30 ml的流體。The first syringe 24 is adapted to collect and contain an upper layer of the blood sample (containing the small-cell portion of the blood sample) located in the blood container 23 after gravity separation. The first syringe 24 is a pump comprising a first barrel 24a [e.g., a cylindrical tube], a first plunger located within the first barrel 24a. 24b and a first opening 24c. The second syringe 25 is adapted to contain an upper layer of the blood sample flowing from the first syringe 24 via the tube 26c. The second syringe 25 includes, for example, a second barrel 25a (e.g., a cylindrical tube), a second plunger 25b positioned within the second barrel 25a, and a second Second opening 25c. The first syringe 24 can be adapted to contain 10% to 200% more than the second syringe 25 (eg, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90) %, 100%, 150% or 200%) of the fluid. For example, the first syringe 24 can hold 60 ml of fluid while the second syringe 25 can hold 30 ml of fluid.

該第一柱塞24b被配置成要被該血液分離裝置1之一泵驅動器5來驅動俾以沿著該第一注射器24的該第一筒24a之一軸向(axial direction)來相對於該第一筒24a移動。舉例而言,當該第一柱塞24b被該泵驅動器5所驅動而相對於該第一筒24a沿著該軸向被拉動(pulled)時,該血液樣品的上層從該血液容器23依序地經由該管26a、該止回閥27、該管26b以及該第一開口24c而流動至該第一筒24a之內。該拋棄式匣2之一擋板(hard stop) 28a被調適成用以防止該第一柱塞24b在該泵驅動器5發生故障(malfunction)的情況下從該第一筒24a中脫出。當該第一注射器24的該第一柱塞24b被該泵驅動器5所驅動而相對於該第一筒24a沿著該軸向被推動(pushed)時,位於該第一筒24a內之一部分的該血液樣品的上層經由該管26c以及該第二開口25c而流動至該第二注射器25的該第二筒25a之內。該拋棄式匣2之一擋板28b被調適成用以防止該第二柱塞25b在該泵驅動器5發生故障的情況下從該第二筒25a中脫出。總結來說,該第一柱塞24b可藉由該血液分離裝置1之泵驅動器5而於該第一筒24a之內被拉動和推動,容許該第一注射器24經由該開口24c來吸入和排出一液體(例如該血液樣品的上層)。The first plunger 24b is configured to be driven by a pump driver 5 of the blood separation device 1 to be along an axial direction of the first barrel 24a of the first syringe 24 relative to the The first cylinder 24a moves. For example, when the first plunger 24b is driven by the pump driver 5 and is pulled along the axial direction relative to the first barrel 24a, the upper layer of the blood sample is sequentially ordered from the blood container 23. The ground flows into the first cylinder 24a via the tube 26a, the check valve 27, the tube 26b, and the first opening 24c. A disposable stop 28a is adapted to prevent the first plunger 24b from coming out of the first barrel 24a in the event of a malfunction of the pump driver 5. When the first plunger 24b of the first syringe 24 is driven by the pump driver 5 and is pushed along the axial direction relative to the first barrel 24a, a portion of the first barrel 24a is located The upper layer of the blood sample flows into the second barrel 25a of the second syringe 25 via the tube 26c and the second opening 25c. One of the disposal plates 2b of the disposable crucible 2b is adapted to prevent the second plunger 25b from coming out of the second cylinder 25a in the event of a failure of the pump driver 5. In summary, the first plunger 24b can be pulled and pushed within the first barrel 24a by the pump driver 5 of the blood separation device 1, allowing the first syringe 24 to be sucked in and discharged through the opening 24c. A liquid (eg, the upper layer of the blood sample).

該拋棄式匣2進一步包含一被預先負載(preloaded)於該血液容器23之內以便跟該血液樣品混合之以二價陽離子螯合為基礎的抗凝血劑(divalent cation chelating-based anticoagulant)。舉例來說,該以二價陽離子螯合為基礎的抗凝血劑是乙二胺四乙酸(ethylenediaminetetraacetic acid, EDTA)、檸檬酸鹽(citrate)或其他的鈣螯合抗凝血劑(calcium-chelating anticoagulant)。在一個具體例中,該血液容器23含有一數量的該以二價陽離子螯合為基礎的抗凝血劑,而使得該抗凝血劑被混合以該血液樣品之後,該血液樣品在每毫升血液樣品中含有1.5 mg或更多(例如1.5 mg 至2 mg、1.6 mg、1.7 mg、1.8 mg、1.9 mg或2 mg)的抗凝血劑。在一個具體例中,如圖2中所示的,該拋棄式匣2進一步包含一被安裝置該管26a的過濾器(filter) 31。該過濾器31被調適成用以過濾該血液樣品中的白血球(leukocytes)。The disposable crucible 2 further includes a divalent cation chelating-based anticoagulant that is preloaded within the blood container 23 for mixing with the blood sample. For example, the anticoagulant based on divalent cation chelation is ethylenediaminetetraacetic acid (EDTA), citrate or other calcium chelate anticoagulant (calcium- Chelating anticoagulant). In one embodiment, the blood container 23 contains an amount of the anticoagulant based on the divalent cation chelation, and after the anticoagulant is mixed with the blood sample, the blood sample is in each milliliter. The blood sample contains 1.5 mg or more (eg 1.5 mg to 2 mg, 1.6 mg, 1.7 mg, 1.8 mg, 1.9 mg or 2 mg) of anticoagulant. In one embodiment, as shown in Figure 2, the disposable cassette 2 further includes a filter 31 that is mounted to the tube 26a. The filter 31 is adapted to filter leukocytes in the blood sample.

參照圖1,該血液分離裝置1 (它被調適成供該拋棄式匣2之用俾以分離位於該拋棄式匣2之血液容器23內的血液樣品)包含一控制器3、一被耦合至該控制器3的RBC偵測模組4以及被耦合至該控制器3的該泵驅動器5 [例如一泵或致動器(actuator)]。該RBC偵測模組4被調適成用以在該血液樣品流經該管26a時,於一偵測點30之處偵測該血液樣品內的紅血球,俾以產生一要被傳送至該控制器3的偵測信號(detection signal)。該RBC偵測模組4包含,舉例來說,一被調適成用以對位在該偵測點30之處的該管26a發射一光的發光元件(light emitting device)以及一被調適成用以偵測明確地表示流經位在該偵測點30之處的該管26a之血液樣品中有紅血球存在的該光之反射、散射、吸收或螢光的感測器(sensor)。該RBC偵測模組4可被放置而使得介於該開口23a和該偵測點30之間的流動通道(flow path)具有一距離要比那個為介於該偵測點30和該第一開口24c之間的流動通道所具者為低(例如,要低1至95%、3%、5%、10%、15%、20%、25%、30%、35%、40%、45%、50%、55%、60%、65%、70%、75%、80%、85%、90%或95%)。該RBC偵測模組4被調適成當位於該偵測點30之處的該管26a是澄清的(clear)之時來執行一紅血球偵測。該RBC檢測模塊4被調適成能容忍氣泡(bubbles)、“薄片(flakes)”[雜散的紅血球(stray red blood cells)]的存在以及位於該血液樣品的上層和該血液樣品的下層之間的線(line)的擴散(spread),俾以防止在該上層從該血液容器23至該第一注射器24的完全轉移之前過早產生會結束泵送的偵測信號。Referring to Figure 1, the blood separation device 1 (which is adapted for use with the disposable cartridge 2 to separate a blood sample located in the blood container 23 of the disposable cartridge 2) includes a controller 3 coupled to The RBC detection module 4 of the controller 3 and the pump driver 5 (e.g., a pump or actuator) coupled to the controller 3. The RBC detection module 4 is adapted to detect red blood cells in the blood sample at a detection point 30 when the blood sample flows through the tube 26a, to generate a to be transmitted to the control The detection signal of the device 3. The RBC detection module 4 includes, for example, a light emitting device adapted to emit a light to the tube 26a located at the detecting point 30, and an adapted light emitting device. A sensor that reflects, reflects, scatters, absorbs, or fluoresces the red blood cells present in the blood sample of the tube 26a flowing through the detection point 30 is detected. The RBC detection module 4 can be placed such that a flow path between the opening 23a and the detection point 30 has a distance greater than the detection point 30 and the first The flow passage between the openings 24c is low (for example, 1 to 95%, 3%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45) %, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95%). The RBC detection module 4 is adapted to perform a red blood cell detection when the tube 26a located at the detection point 30 is clear. The RBC detection module 4 is adapted to tolerate the presence of bubbles, "flakes" [stray red blood cells] and between the upper layer of the blood sample and the lower layer of the blood sample The spread of the line prevents the premature generation of the detection signal that will end the pumping before the upper layer completely transfers from the blood container 23 to the first syringe 24.

該RBC偵測模組4可被調適成用來進行圖3中所示的處理程序。該發光元件可包含一第一發光二極體(light-emitting diode, LED)發射一具有波長為461 nm的藍光,以及一第二綠光LED發射一具有波長為565 nm波長的綠光。該感測器可包含一或多個光電二極管(photodiodes)[例如,矽光電二極管(silicon photodiodes)]被調適成用來偵測發射自各個LED的光。該RBC偵測模組4可被調適成用以在一匣被定位至該血液分離裝置之前執行一校正順序(calibration sequence)。在收到一校正要求(calibration request)(例如,來自該中央控制單元或該血液分離裝置)之後,有關於綠光和藍光波道(the green and the blue channels)的光位準(light levels)在該等LEDs被開啟(with the LEDs on)以及該等LEDs被關閉(with the LEDs off)之下被測量。有關於各個LED的電流(current)被獨立地設定,要求是一次只做一個光測量(light measurement),在該等藍光和綠光LEDs之間快速地交替。這些校正測量(calibration measurements)是在該匣沒有位在該血液分離裝置之內時被執行。該校正過程(calibration process)設定最大亮度和最大暗度(maximum bright and maximum dark levels)。這些位準,還有由該等LEDs所牽動的電流,可以被檢查俾以確定它們是否有處於預期的容許帶(expected tolerance bands)之內。吸收位準(absorption levels)接而在針對該綠光和藍光波道此二者的這兩個位準之間被刻度化(scaled)。參見圖4。The RBC detection module 4 can be adapted to perform the processing procedure shown in FIG. The light emitting device may include a first light-emitting diode (LED) emitting blue light having a wavelength of 461 nm, and a second green light emitting light emitting green light having a wavelength of 565 nm. The sensor can include one or more photodiodes (eg, photo photodiodes) that are adapted to detect light emitted from each of the LEDs. The RBC detection module 4 can be adapted to perform a calibration sequence prior to being positioned in the blood separation device. After receiving a calibration request (eg, from the central control unit or the blood separation device), there are light levels for the green and the blue channels. The LEDs are measured with the LEDs on and the LEDs off. The currents associated with the individual LEDs are independently set, requiring only one light measurement at a time, alternating rapidly between the blue and green LEDs. These calibration measurements are performed when the crucible is not located within the blood separation device. The calibration process sets maximum bright and maximum dark levels. These levels, as well as the currents drawn by the LEDs, can be checked to determine if they are within the expected expected bands. The absorption levels are then scaled between the two levels for both the green and blue channels. See Figure 4.

參照圖3,該RBC偵測模組具有3個輸出信號銷(output signal pins),亦即狀態1 (Status 1)、狀態2 (Status 2)以及錯誤(Fault)。該偵測器(detector)亦具有1個輸入信號銷(input signal pin),亦即校正要求。如果該偵測器通過校正,輸出銷(output pin)會指示一個“無管(No Tube)”狀況,例如該血液分離裝置之內不存在有該匣。該“無管”狀況係發生於當該綠光和藍光波道此二者偵測到近乎最大亮度,例如最少量的光吸收。下一個吸收位準發生於一“頂層(Top Layer)”狀況,例如當來自於該匣中的血液容器之一部分的上層流經該偵測點之時。該綠光波道更適於測量這個狀況。如果綠光吸收位準是低於一特定位準(參見圖4),該等輸出銷會指示一“頂層”狀況。下一個吸收位準發生於一“空管(Empty Tube)”狀況。這是一個裡面空無一物的管子,或者如果有一氣泡流經該偵測點。該藍光波道更適於測量這個狀況。如果藍光吸收位準是低於一特定位準(參見圖4),該等輸出銷會指示一“空管”狀況。最後一個吸收位準發生於“血液(Blood)”狀況,例如當紅血球流經偵測點之時。該藍光波道更適於測量這個狀況。如果藍光吸收位準超過一特定位準(參見圖4),該等輸出銷會指示一“血液”狀況。Referring to FIG. 3, the RBC detection module has three output signal pins, that is, status 1 (Status 1), status 2 (Status 2), and fault (Fault). The detector also has an input signal pin, which is a calibration requirement. If the detector passes the correction, the output pin will indicate a "No Tube" condition, such as the absence of the defect within the blood separation device. This "tubeless" condition occurs when both the green and blue light channels detect near maximum brightness, such as a minimum amount of light absorption. The next absorption level occurs in a "Top Layer" condition, such as when an upper layer from a portion of the blood container in the cassette flows through the detection point. This green light channel is more suitable for measuring this condition. If the green absorption level is below a certain level (see Figure 4), the output pins will indicate a "top" condition. The next absorption level occurs in an "Empty Tube" condition. This is a tube with nothing inside, or if a bubble flows through the detection point. This blue light channel is more suitable for measuring this condition. If the blue absorption level is below a certain level (see Figure 4), the output pins will indicate an "empty tube" condition. The last absorption level occurs in a "Blood" condition, such as when a red blood cell flows through a detection point. This blue light channel is more suitable for measuring this condition. If the blue light absorption level exceeds a certain level (see Figure 4), the output pins will indicate a "blood" condition.

參照圖1,該控制器3,舉例而言,是一個微控器(microcontroller),它是一個單一的積體電路晶片(single integrated circuit chip)含有一處理器核心(processor core)、記憶體(memory)以及可程式化輸入/輸出週邊(programmable input/output peripherals)。該控制器3被調適成用以接收來自該RBC偵測模組4的偵測信號,並且在接收該偵測信號之後產生一要被傳送至該泵驅動器5的驅動信號。該泵驅動器5被調適成用以接收來自該控制器3的驅動信號,保持該第一注射器24的第一柱塞24b,以及驅動該第一柱塞24b相對於該第一筒24a來沿著該第一筒24a的軸向移動。因此,根據偵測結果或信號,該泵驅動器5被配置成用以驅動該血液容器23中的一部分血液樣品依序地流經位在該管26a中的偵測點30、該止回閥27、該管26b以及該開口24c而至該第一筒24a之內。Referring to FIG. 1, the controller 3 is, for example, a microcontroller, which is a single integrated circuit chip including a processor core and a memory ( Memory) and programmable input/output peripherals. The controller 3 is adapted to receive a detection signal from the RBC detection module 4 and generate a drive signal to be transmitted to the pump driver 5 after receiving the detection signal. The pump driver 5 is adapted to receive a drive signal from the controller 3, hold the first plunger 24b of the first syringe 24, and drive the first plunger 24b along the first barrel 24a along The axial movement of the first cylinder 24a. Therefore, based on the detection result or signal, the pump driver 5 is configured to drive a portion of the blood sample in the blood container 23 to sequentially flow through the detection point 30 located in the tube 26a, the check valve 27 The tube 26b and the opening 24c are inside the first barrel 24a.

該血液分離裝置1進一步包含一冷卻模組6 [例如,一熱電冷卻器(thermoelectric cooler)、一蒸汽壓縮冷卻器(vapor-compression cooler)或一液體冷卻器(liquid cooler)]被調適成用以冷卻該血液容器23中的血液樣品,一被耦合至該控制器3的溫度感測器7,以及一冷卻驅動器8 [例如,一個熱電驅動器(thermoelectric driver)]被耦合至該控制器3和該冷卻模組6此二者並且被調適成根據一來自該溫度感測器7的反饋(feedback)來驅動該冷卻模組6。該溫度感測器7被調適成用以感測一與該血液容器23中的血液樣品有關聯的溫度,諸如該拋棄式匣2之一內溫(internal temperature),俾以產生一要被傳送至該控制器3的溫度感測器信號(temperature sensor signal)。該控制器3被調適成用以接收該溫度感測器信號並且根據該溫度感測器信號來產生一要被傳送至該冷卻驅動器8的冷卻信號(cooling signal)。該冷卻驅動器8被調適成用以接收該冷卻信號,並且在接收該冷卻信號之後驅動該冷卻模組6,俾以冷卻與該血液容器23中的血液樣品有關聯的溫度。在一個具體例中,該控制器3、該冷卻模組6、該溫度感測器7以及該冷卻驅動器8一起被調適成用以冷卻和維持與該血液容器23中的血液樣品有關聯的溫度至一介於攝氏2度(℃)和12℃之間的溫度,例如2℃、3℃、4℃、5℃、6℃、7℃、8℃、9℃、10℃、11℃、12℃、2至7℃、2至10℃、4至8℃、4至12℃,或6至12℃。該血液分離裝置1的支持件11可被使用作為一個傳熱座(heat transfer mount),它被調適成用以從該血液容器23將熱移除到該冷卻模組6。該血液分離裝置1之一被動式熱交換器(passive heat exchanger) 9 (例如一個散熱座)被調適成用以從該冷卻模組6將熱傳導至該血液分離裝置1的周圍(ambient)。該血液分離裝置1之一風扇(fan) 10被調適成用以移除被傳導至該被動式熱交換器9的熱至該血液分離裝置1的周圍。在一個具體例中,該支持件11被調適成用以按壓該血液容器23抵靠著該冷卻模組6,俾以增加該血液容器23和該冷卻模組6之間的接觸表面(contact surface)。The blood separation device 1 further includes a cooling module 6 [eg, a thermoelectric cooler, a vapor-compression cooler or a liquid cooler] adapted to be used Cooling a blood sample in the blood container 23, a temperature sensor 7 coupled to the controller 3, and a cooling driver 8 [eg, a thermoelectric driver] coupled to the controller 3 and the Both of the cooling modules 6 are adapted to drive the cooling module 6 based on a feedback from the temperature sensor 7. The temperature sensor 7 is adapted to sense a temperature associated with a blood sample in the blood container 23, such as an internal temperature of the disposable cassette 2, to produce a to be delivered A temperature sensor signal to the controller 3. The controller 3 is adapted to receive the temperature sensor signal and generate a cooling signal to be transmitted to the cooling driver 8 based on the temperature sensor signal. The cooling drive 8 is adapted to receive the cooling signal and to drive the cooling module 6 after receiving the cooling signal to cool the temperature associated with the blood sample in the blood container 23. In one embodiment, the controller 3, the cooling module 6, the temperature sensor 7, and the cooling driver 8 are adapted to cool and maintain a temperature associated with a blood sample in the blood container 23. To a temperature between 2 degrees Celsius (°C) and 12°C, such as 2°C, 3°C, 4°C, 5°C, 6°C, 7°C, 8°C, 9°C, 10°C, 11°C, 12°C 2 to 7 ° C, 2 to 10 ° C, 4 to 8 ° C, 4 to 12 ° C, or 6 to 12 ° C. The support 11 of the blood separation device 1 can be used as a heat transfer mount that is adapted to remove heat from the blood container 23 to the cooling module 6. A passive heat exchanger 9 (e.g., a heat sink) of the blood separation device 1 is adapted to conduct heat from the cooling module 6 to the ambient of the blood separation device 1. A fan 10 of the blood separation device 1 is adapted to remove heat conducted to the passive heat exchanger 9 to the periphery of the blood separation device 1. In a specific example, the support member 11 is adapted to press the blood container 23 against the cooling module 6 to increase the contact surface between the blood container 23 and the cooling module 6 ).

該血液分離裝置1的支持件11可被調適成用以撐住含有該血液樣品的該血液容器23俾以防止它倒下。該拋棄式匣2被調適成要藉由該血液分離裝置1之一鎖定機構(locking mechanism) 12 [例如一個電子鎖定機構(electric locking mechanism)]而被鎖定在該血液分離裝置1之內。該鎖定機構12被耦合至該控制器3並且被調適成要根據一傳送自該控制器3的信號來鎖定或鬆開(unlock)該拋棄式匣2。換言之,該控制器3被調適成用以控制該鎖定機構12來鎖定或鬆開該拋棄式匣2。該鎖定機構12可被耦合以一個可為拋棄式的就位開關(in-place switch)或偵測器。任擇地,該就位開關或偵測器可被整合至該該鎖定機構12之內。該就位開關或偵測器被調適成用以確認該拋棄式匣2是否有正確地就位於該血液分離裝置1之內。The support member 11 of the blood separation device 1 can be adapted to hold the blood container 23 containing the blood sample to prevent it from falling down. The disposable crucible 2 is adapted to be locked within the blood separation device 1 by a locking mechanism 12 [e.g., an electric locking mechanism] of the blood separation device 1. The locking mechanism 12 is coupled to the controller 3 and is adapted to lock or unlock the disposable cassette 2 in response to a signal transmitted from the controller 3. In other words, the controller 3 is adapted to control the locking mechanism 12 to lock or release the disposable cassette 2. The locking mechanism 12 can be coupled to a disposable in-place switch or detector. Optionally, the seating switch or detector can be integrated into the locking mechanism 12. The position switch or detector is adapted to confirm that the disposable cassette 2 is properly positioned within the blood separation device 1.

再者,該血液分離裝置1包含一被耦合至該控制器3的無線模組(wireless module) 13,一被耦合至該控制器3的識別(identification, ID)模組14,一被耦合至該控制器3的呼叫器(beeper) 15,一被耦合至該控制器3的啟動按鈕(start button) 16,一被耦合至該控制器3的停止按鈕(stop button) 17,一被耦合至該控制器3的狀態顯示(status displays ) 18,一被耦合至該控制器3的液晶顯示器(liquid crystal display, LCD) 19,一被耦合至該控制器3的測試埠(test port) 20,一電源進入模組(power entry module) 21,以及一被耦合至該電源進入模組21的交直流電源供應模組(AC-to-DC power supply module) 22。Furthermore, the blood separation device 1 includes a wireless module 13 coupled to the controller 3, an identification (ID) module 14 coupled to the controller 3, coupled to A beeper 15 of the controller 3 is coupled to a start button 16 of the controller 3, a stop button coupled to the controller 3, a coupled to The status display s 18 of the controller 3, a liquid crystal display (LCD) 19 coupled to the controller 3, a test port coupled to the controller 3 A power entry module 21 and an AC-to-DC power supply module 22 coupled to the power entry module 21.

該無線模組13被調適成用以允許介於該血液分離裝置1和該中央控制單元之間的無線通信。一被使用於該無線通信的通信協定(protocol)可為一Wi-Fi通信協定,諸如IEEE 802.11。該識別模組14被調適成具有一要被傳送至該中央控制單元的唯一識別碼(unique identifier)[亦即一電子產品碼(electronic product code)],它可以是與一給定系統(given system)(例如該分離系統)之內的一個單一實體(single entity)(例如該血液分離裝置1)有關聯之一數字或文數字字串(numeric or alphanumeric string)。舉例而言,該識別模組14可為一無線射頻識別(radio-frequency identification, RFID)晶片(chip)或電子標籤(tag),它可以經由一無線電波(radio wave)將該唯一識別碼傳送至該中央控制單元。該中央控制單元能夠讀取由該無線電波所攜帶的唯一識別碼並且經由該唯一識別碼來識別該血液分離裝置1。任擇地,該識別模組14可為一可抹除可程式化唯讀記憶體(erasable programmable read-only memory, EPROM)晶片,它包含該唯一識別碼。該中央控制單元能夠讀取被儲存於該EPROM晶片內的唯一識別碼並且經由該唯一識別碼來識別該血液分離裝置1。The wireless module 13 is adapted to allow wireless communication between the blood separation device 1 and the central control unit. A protocol used for the wireless communication may be a Wi-Fi communication protocol such as IEEE 802.11. The identification module 14 is adapted to have a unique identifier (i.e., an electronic product code) to be transmitted to the central control unit, which may be associated with a given system (given A single entity (e.g., the blood separation device 1) within a system (e.g., the separation system) is associated with a numeric or alphanumeric string. For example, the identification module 14 can be a radio-frequency identification (RFID) chip or an electronic tag, which can transmit the unique identification code via a radio wave. To the central control unit. The central control unit is capable of reading a unique identification code carried by the radio wave and identifying the blood separation device 1 via the unique identification code. Optionally, the identification module 14 can be an erasable programmable read-only memory (EPROM) chip that includes the unique identification code. The central control unit is capable of reading a unique identification code stored in the EPROM wafer and identifying the blood separation device 1 via the unique identification code.

該呼叫器15可發出一聲音來告知一使用者一異常事件或問題(abnormal event or a problem)已於該血液分離裝置1之內發生。該啟動按鈕16被調適成用以送出一啟動信號(start signal)至該控制器3以開始一用以分離血液容器23內的血液樣品之處理程序。該停止按鈕17被調適成用以送出一停止信號(stop signal)至該控制器3以打斷(abort)或終止(terminate)該用以分離該血液樣品之處理程序。該狀態顯示18,諸如發光二極體(LEDs),可發射光以警示(alert)一使用者去注意該血液分離裝置1之一狀態,例如一電源開啟(power-on)和/或錯誤狀態。該液晶顯示器19 [它是一個使用液晶的光調變性質(light-modulating properties)的平板顯示器(flat-panel display)或其他的電子視覺顯示器(electronic visual display)]被調適成用以顯示有關該用以分離該血液樣品之處理程序的資訊(information)。該測試埠20,諸如一個RS-232串聯埠,被調適成要在測試和維護期間被使用以下載日誌(download logs)以及允許非使用者診斷(non-user diagnostics)。The pager 15 can emit a sound to inform a user that an abnormal event or a problem has occurred within the blood separation device 1. The start button 16 is adapted to send a start signal to the controller 3 to initiate a process for separating blood samples in the blood container 23. The stop button 17 is adapted to send a stop signal to the controller 3 to abort or terminate the process for separating the blood sample. The status display 18, such as light emitting diodes (LEDs), can emit light to alert a user to a state of the blood separation device 1, such as a power-on and/or error state. . The liquid crystal display 19 [which is a flat-panel display or other electronic visual display using light-modulating properties of liquid crystals) is adapted to display the relevant Information used to isolate the processing of the blood sample. The test 埠 20, such as an RS-232 serial port, is adapted to be used during test and maintenance to download logs and to allow non-user diagnostics.

該電源進入模組21,舉例而言,可為一被使用於該血液分離裝置1內的電化學組件(electromechanical component),整合一電源入口(power inlet)與其他組件[諸如一開關和一保險絲座(fuse holder)]。該電源進入模組21被調適成用以藉由一電源線(power supply cord)來連接一外部電源(external power source)並提供交流電(alternating current, AC)電源輸入(power input)給該交直流電源供應模組22。該交直流電源供應模組22,諸如一個交直流電壓轉換器(AC-to-DC voltage converter),被調適成用以將來自該電源進入模組21的交流電力(AC power)轉換成直流電力(DC power)以供電給所有的該等組件3-20。The power entry module 21, for example, can be an electrochemical component used in the blood separation device 1, integrating a power inlet with other components [such as a switch and a fuse Fuse holder]. The power entry module 21 is adapted to be connected to an external power source by a power supply cord and to provide an alternating current (AC) power input to the AC and DC. Power supply module 22. The AC/DC power supply module 22, such as an AC-to-DC voltage converter, is adapted to convert AC power from the power entry module 21 into DC power. (DC power) to supply all of these components 3-20.

該血液分離裝置1可進一步包含一外殼(housing),它含有上述組件3-22。一位於該外殼之內的空間(space)[例如一插座(socket)]被配置成用以容置要藉由該鎖定機構12而被可拆卸地鎖定至該血液分離裝置1的該拋棄式匣2。在該血液分離裝置1中,該控制器3被調適成用以控制和協調所有的該等組件3-22。舉例而言,該控制器3可執行下列操作:(1)在接收一來自該中央控制單元或來自該啟動按鈕16的開始指令(start command)之後啟動一用以分離該血液樣品的處理程序,(2)操作該鎖定機構12以便在接收一來自該中央控制單元或該啟動按鈕16的指令或信號之後鎖定該拋棄式匣2或者在接收一來自該中央控制單元或該停止按鈕17的指令或信號之後鬆開該拋棄式匣2,(3)監視該泵驅動器5的電路(circuitry)以偵測過量電流(excessive current)(如果該第一注射器24被阻塞)或者無電流(如果該第一注射器24沒有與該泵驅動器5正確地接合),(4)即使無線或有線通信中輟(drops out),完成該處理程序,以及(5)在接收一來自該中央控制單元或該停止按鈕17的停止指令(stop command)或信號之後打斷該處理程序。該控制器3可含有一電池備援的時鐘/計時器(battery backed up clock/timer)以允許該用以分離血液樣品的處理程序在處理經過時間(elapsed processing time)的監視,即使經由一功率損失(loss of power)。任擇地,該血液分離裝置1可含有一維生電路(keep-alive circuit),它被調適成用以接收來自該控制器3的週期性脈波(periodic pulses)(至少每秒一次)。如果兩個或更多的來自該控制器3的脈波被漏失或沒被該維生電路接收到,通至該泵驅動器5以及通至該冷卻模組6的電力被關閉。The blood separation device 1 may further comprise a housing containing the above components 3-22. A space (e.g., a socket) located within the housing is configured to receive the disposable cassette to be detachably locked to the blood separation device 1 by the locking mechanism 12. 2. In the blood separation device 1, the controller 3 is adapted to control and coordinate all of the components 3-22. For example, the controller 3 can perform the following operations: (1) starting a processing procedure for separating the blood sample after receiving a start command from the central control unit or from the start button 16, (2) operating the locking mechanism 12 to lock the disposable cassette 2 or receive an instruction from the central control unit or the stop button 17 after receiving an instruction or signal from the central control unit or the activation button 16 The signal is then released from the disposable 匣2, (3) monitoring the circuit of the pump driver 5 to detect an excess current (if the first injector 24 is blocked) or no current (if the first The syringe 24 is not properly engaged with the pump driver 5, (4) completes the process even if it is dropped out in wireless or wired communication, and (5) receives a command from the central control unit or the stop button 17 The handler is interrupted after a stop command or signal. The controller 3 may include a battery backed up clock/timer to allow monitoring of the elapsed processing time of the processing routine for separating the blood sample, even via a power Loss of power. Optionally, the blood separation device 1 can include a keep-alive circuit adapted to receive periodic pulses from the controller 3 (at least once per second). If two or more pulses from the controller 3 are lost or not received by the living circuit, the power to the pump driver 5 and to the cooling module 6 is turned off.

總結來說,該分離系統包含如圖1中所圖解說明的該血液分離裝置1 (能夠與一中央控制單元連通)以及被配置成要被定位於該血液分離裝置1之內的如圖1或圖2中所圖解說明的該單次使用匣2。該中央控制單元被調適成用以運行軟體(run software)以允許一使用者藉由無線或有線通信來控制該血液分離裝置1之一或多個功能。該血液分離裝置1可藉由它的無線模組13或它的乙太網路模組(Ethernet module)來與該中央控制單元連通。該血液分離裝置1包含一件可再用設備(a reusable piece of equipment)係由要安全地執行血液分離所必需的所有電子、機械、光學和熱控制裝置(electronic, mechanical, optical and thermal control devices)(例如該等組件3-22)所組成。In summary, the separation system comprises the blood separation device 1 (which is capable of communicating with a central control unit) as illustrated in Figure 1 and is configured to be positioned within the blood separation device 1 as shown in Figure 1 or This single use 匣2 illustrated in Figure 2. The central control unit is adapted to run software to allow a user to control one or more functions of the blood separation device 1 by wireless or wired communication. The blood separation device 1 can be in communication with the central control unit via its wireless module 13 or its Ethernet module. The blood separation device 1 comprises a reusable piece of equipment for all electronic, mechanical, optical and thermal control devices necessary for safely performing blood separation (electronic, mechanical, optical and thermal control devices). ) (for example, these components 3-22).

在另一個具體例中,一分離系統被提供,它包含至少兩個血液分離裝置1 (每一者係如圖1中所圖解說明的)以及至少兩個被配置成要被定位於各別的血液分離裝置1之內的單次使用匣2 (每一者係如圖1或圖2中所圖解說明的)。一中央控制單元被調適成用以用以運行軟體以允許一使用者藉由無線或有線通信來控制該一或多個血液分離裝置1的功能。該等血液分離裝置1的每一者可藉由它的無線模組13或它的乙太網路模組來與該中央控制單元連通。該中央控制單元能夠連接至一能讀取一被整合至該等匣2之每一者之內的序列化唯一識別碼(serialized unique identifier)之週邊裝置(peripheral device)。舉例而言,該週邊裝置可為一條碼讀取器(barcode reader),而該序列化唯一識別碼可為一列印條碼(printed barcode)。任擇地,該週邊裝置可為一無線射頻識別(RFID)讀取器,而該序列化唯一識別碼可為一RFID碼。該等序列化唯一識別碼之每一者,舉例來說,可被聯結至一個別病患的資訊並且可在處理和治療期間的一或多個點被讀取,俾以防止病患樣品的意外交換(accidental exchange)。該等血液分離裝置1的每一者包含一件可再用設備係由要安全地執行血液分離所必需的所有電子、機械、光學和熱控制裝置( (例如該等組件3-22)所組成。In another embodiment, a separation system is provided that includes at least two blood separation devices 1 (each as illustrated in Figure 1) and at least two are configured to be positioned individually A single use 匣2 within the blood separation device 1 (each as illustrated in Figure 1 or Figure 2). A central control unit is adapted to operate the software to allow a user to control the functionality of the one or more blood separation devices 1 by wireless or wired communication. Each of the blood separation devices 1 can be in communication with the central control unit via its wireless module 13 or its Ethernet module. The central control unit is connectable to a peripheral device capable of reading a serialized unique identifier integrated into each of the peers 2. For example, the peripheral device can be a barcode reader, and the serialized unique identification code can be a printed barcode. Optionally, the peripheral device can be a radio frequency identification (RFID) reader, and the serialized unique identification code can be an RFID code. Each of the serialized unique identification codes, for example, can be linked to information of another patient and can be read at one or more points during processing and treatment to prevent patient samples from being Accidental exchange. Each of the blood separation devices 1 comprises a piece of reusable device consisting of all of the electronic, mechanical, optical and thermal control devices (e.g., such components 3-22) necessary to perform blood separation safely. .

一使用該分離系統來分離血液樣品的方法被圖解說明於圖5之中。參照圖5,在一步驟S1中,該血液樣品係從該個體的血液(例如周邊血液)被無菌地抽出至位在該拋棄式匣2之內的含有一以二價陽離子螯合為基礎的抗凝血劑(例如EDTA或檸檬酸鹽)的血液容器23中,而,該血液樣品被混合以該以二價陽離子螯合為基礎的抗凝血劑。在一步驟S2中,該拋棄式匣2被插入或定位至該血液分離裝置1之內,亦即至一位在該血液分離裝置1的外殼之內的插座之中,而位在該拋棄式匣2之內的帶有該血液樣品的該血液容器23被該支持件11所保持。該拋棄式匣2被插入或定位至該血液分離裝置1之內而使得該血液容器23係處於一直立位置。於是,位在被定位於該血液分離裝置1之中的該拋棄式匣2之內的該血液容器23的兩個開口23a和23b之每一者係位在該血液容器23的頂部並且係處於一在重力座標(gravity coordinate)上要比位於該拋棄式匣2的該血液容器23內之血液樣品為高的水平(level)處。A method of separating a blood sample using the separation system is illustrated in FIG. Referring to Fig. 5, in a step S1, the blood sample is aseptically extracted from the blood of the individual (e.g., peripheral blood) to a position containing a divalent cation chelation within the disposable crucible 2. The blood sample 23 of the anticoagulant (e.g., EDTA or citrate) is mixed with the anticoagulant based on the divalent cation chelation. In a step S2, the disposable cassette 2 is inserted or positioned within the blood separation device 1, i.e., into a socket within the outer casing of the blood separation device 1, and is located in the disposable The blood container 23 with the blood sample within the crucible 2 is held by the support member 11. The disposable cartridge 2 is inserted or positioned within the blood separation device 1 such that the blood container 23 is in an upright position. Thus, each of the two openings 23a and 23b of the blood container 23 positioned within the disposable crucible 2 located in the blood separation device 1 is tied to the top of the blood container 23 and is at One is at a higher level on the gravity coordinate than the blood sample in the blood container 23 of the disposable cassette.

其次,在接收一來自該中央控制單元或來自該血液分離裝置1之啟動按鈕16的啟動信號之後,該血液分離裝置1依序地執行下列步驟S3-S5。在一步驟S3中,該血液分離裝置1之冷卻模組6被驅動俾以冷卻位於該拋棄式匣2的血液容器23之內的血液樣品並且將之維持在一特定溫度(specific temperature)下歷時一段預定的時間,例如,3至72小時、3至12小時、3 to 18小時、3至24小時、3至36小時、3至48小時、3至60小時、6至72小時、6至12小時、6至18小時、6至24小時、6至36小時、6至48小時、6至60小時、12至72小時、12至18小時、12至24小時、12至36小時、12至48小時、12至60小時、16至72小時、16至18小時、16至24小時、16至36小時、16至48小時、16至60小時、24至72小時、24至36小時、24至48小時、24至60小時、36至72小時、36至48小時、36至60小時、48至72小時,或48至60小時。該特定溫度可為介2℃和12℃,例如2℃、3℃、4℃、5℃、6℃、7℃、8℃、9℃、10℃、11℃、12℃、2至7℃、2至10℃、4至8℃、4至12℃,或6至12℃。在已被儲存於該特定溫度之下歷時一段預定的時間之後,因為重力,例如只有重力,位在被定位於該血液分離裝置1之中的該拋棄式匣2的血液容器23之內的血液樣品,分離成為包含一上層和一下層之兩個或更多個分開的層。該血液樣品的上層含有諸如小類幹細胞(small stem-like cells)(例如小成體幹細胞)之散浮的小細胞(suspended small cells)以及血小板。位於該血液樣品的上層中的血小板可能為不具活性的(non-viable),舉例來說。該血液樣品的下層含有沉積的大細胞(deposited large cells),諸如大成體幹細胞、紅血球和白血球。於是,在該步驟S3中,該血液分離裝置1藉由允許在該拋棄式匣2的血液容器23之內發生大細胞之重力驅動的沉降(gravity-driven sedimentation)而起作用,而該段預定的時間被認為是一沉降時間(sedimentation time)。Next, after receiving an activation signal from the central control unit or the activation button 16 from the blood separation device 1, the blood separation device 1 sequentially performs the following steps S3-S5. In a step S3, the cooling module 6 of the blood separation device 1 is driven to cool a blood sample located within the blood container 23 of the disposable cartridge 2 and maintain it at a specific temperature for a duration. For a predetermined period of time, for example, 3 to 72 hours, 3 to 12 hours, 3 to 18 hours, 3 to 24 hours, 3 to 36 hours, 3 to 48 hours, 3 to 60 hours, 6 to 72 hours, 6 to 12 Hours, 6 to 18 hours, 6 to 24 hours, 6 to 36 hours, 6 to 48 hours, 6 to 60 hours, 12 to 72 hours, 12 to 18 hours, 12 to 24 hours, 12 to 36 hours, 12 to 48 Hours, 12 to 60 hours, 16 to 72 hours, 16 to 18 hours, 16 to 24 hours, 16 to 36 hours, 16 to 48 hours, 16 to 60 hours, 24 to 72 hours, 24 to 36 hours, 24 to 48 Hours, 24 to 60 hours, 36 to 72 hours, 36 to 48 hours, 36 to 60 hours, 48 to 72 hours, or 48 to 60 hours. The specific temperature may be 2 ° C and 12 ° C, such as 2 ° C, 3 ° C, 4 ° C, 5 ° C, 6 ° C, 7 ° C, 8 ° C, 9 ° C, 10 ° C, 11 ° C, 12 ° C, 2 to 7 ° C 2 to 10 ° C, 4 to 8 ° C, 4 to 12 ° C, or 6 to 12 ° C. After being stored at the specific temperature for a predetermined period of time, due to gravity, for example, only gravity, blood located in the blood container 23 of the disposable cartridge 2 positioned in the blood separation device 1 The sample is separated into two or more separate layers comprising an upper layer and a lower layer. The upper layer of the blood sample contains suspended small cells such as small stem-like cells (e.g., small adult stem cells) and platelets. Platelets located in the upper layer of the blood sample may be non-viable, for example. The lower layer of the blood sample contains deposited large cells such as large adult stem cells, red blood cells, and white blood cells. Thus, in this step S3, the blood separation device 1 functions by allowing gravity-driven sedimentation of large cells within the blood container 23 of the disposable cartridge 2, and the segment is scheduled to be The time is considered to be a sedimentation time.

在一步驟S4中,該控制器3在重力分離之後傳送一第一驅動信號(first driving signal)至該泵驅動器5。在接收該第一驅動信號之後,該泵驅動器5驅動該第一柱塞24a俾以相對於該第一筒24a而沿著該第一筒24a的軸向來拉動該第一柱塞24a。於是,位於該血液容器23內的該血液樣品的上層被泵送出該血液容器23而依序地經由該管26a、該止回閥27、該管26b以及該第一開口24c而至該第一筒24a之內。同時,在該血液樣品流經該管26a時,該RBC偵測模組4於一偵測點30之處偵測該血液樣品內是否有紅血球,俾以產生一要被傳送至該控制器3的偵測信號(它被傳送至該控制器3且為之所接收)。當該RBC偵測模組4偵測到指示紅血球抵達位在該偵測點30之處的該管26a之光時,它產生一偵測信號並將該偵測信號傳送至該控制器3。在接收了從該RBC偵測模組4傳送來的偵測信號之後,該控制器3產生一第二驅動信號(second driving signal)並且將該第二驅動信號傳送至該泵驅動器5。在接收了從該控制器3傳送來的第二偵測信號之後,該泵驅動器5停止拉動該第一柱塞24a以及將該血液樣品抽取至該第一筒24a之內。在一步驟S5中,該控制器3產生一第三驅動信號(third driving signal)以命令該泵驅動器5來相對於該第一筒24a而沿著該第一筒24a的軸向推動該第一柱塞24a,而使得被收集在該第一筒24a內的一部分的該血液樣品的上層經由該管26c而流動至該第二筒25a之內。一旦該第二筒25a被充填以該血液樣品的上層,該控制器3產生一第四驅動信號(fourth driving signal)以命令該泵驅動器5來停止推動該第一柱塞24a以及停止驅動被收集在該第一筒24a內的該血液樣品的上層流入至該第二筒25a之內。該用以分離血液樣品的處理程序於是被完成,而該血液分離裝置1發信號給該中央控制單元。In a step S4, the controller 3 transmits a first driving signal to the pump driver 5 after gravity separation. After receiving the first drive signal, the pump driver 5 drives the first plunger 24a to pull the first plunger 24a along the axial direction of the first barrel 24a with respect to the first barrel 24a. Then, the upper layer of the blood sample located in the blood container 23 is pumped out of the blood container 23, and sequentially passes through the tube 26a, the check valve 27, the tube 26b, and the first opening 24c to the first Inside a tube 24a. At the same time, when the blood sample flows through the tube 26a, the RBC detecting module 4 detects whether there is red blood cells in the blood sample at a detecting point 30, so as to generate a signal to be transmitted to the controller 3. The detection signal (which is transmitted to and received by the controller 3). When the RBC detection module 4 detects the light of the tube 26a indicating that the red blood cell reaches the detection point 30, it generates a detection signal and transmits the detection signal to the controller 3. After receiving the detection signal transmitted from the RBC detection module 4, the controller 3 generates a second driving signal and transmits the second driving signal to the pump driver 5. After receiving the second detection signal transmitted from the controller 3, the pump driver 5 stops pulling the first plunger 24a and draws the blood sample into the first barrel 24a. In a step S5, the controller 3 generates a third driving signal to command the pump driver 5 to push the first one along the axial direction of the first barrel 24a with respect to the first barrel 24a. The plunger 24a causes the upper layer of the blood sample collected in the first barrel 24a to flow into the second barrel 25a via the tube 26c. Once the second cartridge 25a is filled with the upper layer of the blood sample, the controller 3 generates a fourth driving signal to command the pump driver 5 to stop pushing the first plunger 24a and stop driving to be collected. The upper layer of the blood sample in the first cartridge 24a flows into the second cylinder 25a. The process for separating the blood sample is then completed and the blood separation device 1 signals the central control unit.

該血液分離裝置1繼續將該拋棄式匣2安全地維持在上述的特定溫度(例如,介於2℃和12℃之間)之下,直到該拋棄式匣2被一使用者移走。在該拋棄式匣2從該血液分離裝置1被移出之後,含有該血液樣品的上層的該第一注射器24與第二注射器25可從該拋棄式匣2被拆卸出來供一個人[例如一臨床醫師(clinician)、一醫師(doctor)或一研究人員(researcher)]之用。位於該第一注射器24或者該第二注射器25之內的該血液樣品的上層可被使用作為一治療用細胞混合物或一含有幹細胞的溶液以供治療一疾病(disease)或障礙(disorder),諸如一癌症(cancer)、關節炎(arthritis)[例如骨關節炎(osteoarthritis)、牛皮癬性關節炎(psoriatic arthritis)、類風濕性關節炎(rheumatoid arthritis)、關節黏連性脊椎炎(ankylosing spondylitis)]、肌腱炎(tendonitis)、肌腱損傷(tendon injury)或一自體免疫疾病或障礙(autoimmune disease or disorder) [例如類風濕性關節炎、關節黏連性脊椎炎或全身性紅斑性狼瘡(systemic lupus erythematosus)],用於治療關節(joints)、(肌肉)肌腱[(muscle) tendon]、(膝蓋)關節軟骨[(knee) articular cartilage]、肩膀(shoulder)或脊柱(spine),或用於一骨骼-或關節-相關的治療(bone- or joint-related treatment)[例如一牙科植體治療(dental implant treatment)]。位於該第一注射器24或者該第二注射器25之內的該血液樣品的上層可被保存以供其他應用,諸如醫學分析(medical analysis)。The blood separation device 1 continues to safely maintain the disposable crucible 2 below the specific temperature described above (e.g., between 2 ° C and 12 ° C) until the disposable crucible 2 is removed by a user. After the disposable cartridge 2 is removed from the blood separation device 1, the first syringe 24 and the second syringe 25 containing the upper layer of the blood sample can be detached from the disposable cartridge 2 for a person [eg, a clinician (clinician), a doctor (doctor) or a researcher (researcher)]. The upper layer of the blood sample located within the first syringe 24 or the second syringe 25 can be used as a therapeutic cell mixture or a solution containing stem cells for treating a disease or disorder, such as A cancer, arthritis [eg osteoarthritis, psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis] , tendonitis, tendon injury, or autoimmune disease or disorder [eg rheumatoid arthritis, joint adhesion spondylitis, or systemic lupus erythematosus (systemic lupus) Erythematosus)], used to treat joints, (muscle) tendon, (knee) articular cartilage, shoulder or spine, or for Bone- or joint-related treatment [eg, a dental implant treatment]. The upper layer of the blood sample located within the first syringe 24 or the second syringe 25 can be saved for other applications, such as medical analysis.

該血液分離裝置1可由一醫療技術員(medical technician)、護理師(nurse)或醫師(physician)根據提供的操作程序(provided protocols)在醫療點(the point of care)來進行操作。該分離系統被調適成用以在該醫療點來製備一來自一病患的全血(whole blood)之含有幹細胞的溶液(亦即該血液樣品的上層)。術語“自體細胞(autologous cell)”意指一在遺傳上是一個個體自己的細胞。The blood separation device 1 can be operated by a medical technician, a nurse or a physician at a point of care according to a provided protocols. The separation system is adapted to prepare a solution containing stem cells (i.e., the upper layer of the blood sample) from a patient's whole blood at the point of care. The term "autologous cell" means a cell that is genetically an individual's own cell.

不用進一步的闡述,據信一熟習本領域技術者可以根據此處的技術載述來利用本案揭露內容至其最大程度。Without further elaboration, it is believed that one skilled in the art can <RTIgt; </ RTI> <RTIgt;

其他的具體例 被揭示於本案說明書中的所有特徵可以以任一種組合而被組合。被揭示於本案說明書中的每一個特徵可為一供應相同的、等效的或類似的目的(the same, equivalent, or similar purpose)之替代特徵(alternative feature)來取代。因此,除非另有明確地說明,被揭示的每一個特徵僅是一同屬系列(generic series)的等效或相似特徵之一示範例。Other Specific Examples All of the features disclosed in the present specification can be combined in any combination. Each feature disclosed in this specification can be replaced by an alternative feature that provides the same, equivalent, or similar purpose. Thus, unless expressly stated otherwise, each feature disclosed is merely an exemplification of one of the equivalent or similar features of the generic series.

從上面的技術載述,一熟習本領域技術者可以容易地確定被描述的具體例之基本特點,且在不逸脫出其等的精神和範圍之下,可以對該等具體例進行各種不同的改變和修飾以使之能適應各種不同的用途和狀況。因此,其他的具體例亦落入本案申請專利範圍之內。From the above technical description, those skilled in the art can easily determine the basic features of the specific examples described, and can make various changes to the specific examples without departing from the spirit and scope of the invention. The changes and modifications are made to adapt to a variety of different uses and conditions. Therefore, other specific examples also fall within the scope of the patent application of this case.

1‧‧‧血液分離裝置
2‧‧‧拋棄式匣
3‧‧‧控制器
4‧‧‧紅血球(RBC)偵測模組
5‧‧‧泵驅動器
6‧‧‧冷卻模組
7‧‧‧溫度感測器
8‧‧‧冷卻驅動器
9‧‧‧被動式熱交換器、散熱座
10‧‧‧風扇
11‧‧‧支持件
12‧‧‧鎖定機構
13‧‧‧無線模組
14‧‧‧識別(ID)模組
15‧‧‧呼叫器
16‧‧‧啟動按鈕
17‧‧‧停止按鈕
18‧‧‧狀態顯示
19‧‧‧液晶顯示器
20‧‧‧測試埠
21‧‧‧電源進入模組
22‧‧‧交直流電源供應模組
23‧‧‧血液容器
23a、23b‧‧‧開口
24‧‧‧泵、注射器、第一注射器
24a‧‧‧第一筒
24b‧‧‧第一柱塞
24c‧‧‧第一開口、開口
25‧‧‧第二注射器
25a‧‧‧第二筒
25b‧‧‧第二柱塞
25c‧‧‧第二開口
26a、26b、26c‧‧‧管
27‧‧‧止回閥
28a、28b‧‧‧擋板
29‧‧‧魯爾鎖緊接頭、魯爾鎖
30‧‧‧偵測點
31‧‧‧過濾器
S1、S2、S3、S4、S5‧‧‧步驟
1‧‧‧ Blood separation device
2‧‧‧Disposable
3‧‧‧ Controller
4‧‧‧Red Blood Cell (RBC) Detection Module
5‧‧‧ pump driver
6‧‧‧Cooling module
7‧‧‧Temperature Sensor
8‧‧‧Cooling drive
9‧‧‧ Passive heat exchanger, heat sink
10‧‧‧fan
11‧‧‧Support
12‧‧‧Locking mechanism
13‧‧‧Wireless Module
14‧‧‧ Identification (ID) module
15‧‧‧Pager
16‧‧‧Start button
17‧‧‧stop button
18‧‧‧Status display
19‧‧‧LCD display
20‧‧‧Test埠
21‧‧‧Power Entry Module
22‧‧‧AC power supply module
23‧‧‧ blood container
23a, 23b‧‧‧ openings
24‧‧‧ pump, syringe, first syringe
24a‧‧‧ first tube
24b‧‧‧first plunger
24c‧‧‧first opening, opening
25‧‧‧Second syringe
25a‧‧‧second tube
25b‧‧‧second plunger
25c‧‧‧second opening
26a, 26b, 26c‧‧‧ tube
27‧‧‧ check valve
28a, 28b‧‧ ‧ baffle
29‧‧‧Ruhr locking joint, Luer lock
30‧‧‧Detection points
31‧‧‧Filter
S1, S2, S3, S4, S5‧‧ steps

圖1是一示意圖(schematic drawing)顯示一個依據本案揭露內容之一具體例的血液分離裝置具有一被插入於內的拋棄式匣(disposable cartridge)。BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a schematic drawing showing a blood separation device according to one embodiment of the present disclosure having a disposable cartridge inserted therein.

圖2是一示意圖顯示一個依據本案揭露內容之一具體例的血液分離裝置具有一被插入於內的拋棄式匣。Fig. 2 is a schematic view showing a blood separation device according to a specific example of the disclosure of the present invention having a disposable cartridge inserted therein.

圖3是一流程圖(flow chart)圖解說明一種依據本案揭露內容之一具體例的紅血球偵測處理過程(red blood cell detection process)。3 is a flow chart illustrating a red blood cell detection process in accordance with one embodiment of the present disclosure.

圖4是一圖(graph)顯示依據本案揭露內容之一具體例的對應於不同狀態(different states)的光吸收門檻位準(light absorption threshold levels)。4 is a graph showing light absorption threshold levels corresponding to different states in accordance with one embodiment of the present disclosure.

圖5是一流程圖圖解說明一種使用一依據本案揭露內容之一具體例的血液分離系統來分離一衍生自一個體(subject)的血液樣品之方法。Figure 5 is a flow chart illustrating a method of separating a blood sample derived from a subject using a blood separation system in accordance with one embodiment of the present disclosure.

1‧‧‧血液分離裝置 1‧‧‧ Blood separation device

2‧‧‧拋棄式匣 2‧‧‧Disposable

3‧‧‧控制器 3‧‧‧ Controller

4‧‧‧紅血球(RBC)偵測模組 4‧‧‧Red Blood Cell (RBC) Detection Module

5‧‧‧泵驅動器 5‧‧‧ pump driver

6‧‧‧冷卻模組 6‧‧‧Cooling module

7‧‧‧溫度感測器 7‧‧‧Temperature Sensor

8‧‧‧冷卻驅動器 8‧‧‧Cooling drive

9‧‧‧被動式熱交換器、散熱座 9‧‧‧ Passive heat exchanger, heat sink

10‧‧‧風扇 10‧‧‧fan

11‧‧‧支持件 11‧‧‧Support

12‧‧‧鎖定機構 12‧‧‧Locking mechanism

13‧‧‧無線模組 13‧‧‧Wireless Module

14‧‧‧識別(ID)模組 14‧‧‧ Identification (ID) module

15‧‧‧呼叫器 15‧‧‧Pager

16‧‧‧啟動按鈕 16‧‧‧Start button

17‧‧‧停止按鈕 17‧‧‧stop button

18‧‧‧狀態顯示 18‧‧‧Status display

19‧‧‧液晶顯示器 19‧‧‧LCD display

20‧‧‧測試埠 20‧‧‧Test埠

21‧‧‧電源進入模組 21‧‧‧Power Entry Module

22‧‧‧交直流電源供應模組 22‧‧‧AC power supply module

23‧‧‧血液容器 23‧‧‧ blood container

23a、23b‧‧‧開口 23a, 23b‧‧‧ openings

24‧‧‧泵、注射器、第一注射器 24‧‧‧ pump, syringe, first syringe

24a‧‧‧第一筒 24a‧‧‧ first tube

24b‧‧‧第一柱塞 24b‧‧‧first plunger

24c‧‧‧第一開口、開口 24c‧‧‧first opening, opening

25‧‧‧第二注射器 25‧‧‧Second syringe

25a‧‧‧第二筒 25a‧‧‧second tube

25b‧‧‧第二柱塞 25b‧‧‧second plunger

25c‧‧‧第二開口 25c‧‧‧second opening

26a、26b、26c‧‧‧管 26a, 26b, 26c‧‧‧ tube

27‧‧‧止回閥 27‧‧‧ check valve

28a、28b‧‧‧擋板 28a, 28b‧‧ ‧ baffle

29‧‧‧魯爾鎖緊接頭、魯爾鎖 29‧‧‧Ruhr locking joint, Luer lock

30‧‧‧偵測點 30‧‧‧Detection points

Claims (28)

一種分離系統,其包括: 一含有一控制器、一紅血球(RBC)偵測模組以及一泵驅動器的血液分離裝置;以及 一被配置成要被可逆地附接至該血液分離裝置的匣,該匣包含: (i) 一被配置成用以含有一血液樣品的第一容器,其中該第一容器包含一第一開口; (ii) 一與該第一開口呈流體流動連通的配管; (iii) 一與該配管呈流體流動連通的泵,其中該泵被配置成用以將一流體從該第一容器移動至該泵以及用以含有一流體;以及 (iv) 一被安裝至該配管的止回閥,其中該止回閥被配置成用以容許一流體從該第一容器流動至該泵而且不容許一流體從該泵流動至該第一容器。A separation system comprising: a blood separation device including a controller, a red blood cell (RBC) detection module, and a pump driver; and a cassette configured to be reversibly attached to the blood separation device, The crucible comprises: (i) a first container configured to contain a blood sample, wherein the first container includes a first opening; (ii) a tube in fluid flow communication with the first opening; Iii) a pump in fluid flow communication with the pipe, wherein the pump is configured to move a fluid from the first container to the pump and to contain a fluid; and (iv) a pipe to be mounted to the pipe A check valve, wherein the check valve is configured to allow a fluid to flow from the first container to the pump and does not allow a fluid to flow from the pump to the first container. 如請求項1的系統,其中該RBC偵測模組被配置成用以(i)偵測位在一位處於該第一開口和該泵之間的偵測點之處的該配管內的紅血球,以及(ii)當紅血球被偵測到位在該配管之內時,產生一要被傳送至該控制器的第一信號。The system of claim 1, wherein the RBC detection module is configured to (i) detect red blood cells located in the pipe at a detection point between the first opening and the pump And (ii) when the red blood cell is detected to be within the pipe, generating a first signal to be transmitted to the controller. 如請求項2的系統,其中該RBC偵測模組被配置成用以發射一光至該偵測點以及偵測明確地表示紅血球存在於流體中的該光之反射、散射、吸收或螢光。The system of claim 2, wherein the RBC detection module is configured to emit a light to the detection point and to detect reflection, scattering, absorption or fluorescence of the light that clearly indicates that the red blood cell is present in the fluid . 如請求項2或3的系統,其中該控制器被配置成用以接收來自該RBC偵測模組的該第一信號,以及在接收該第一信號之後產生一要被傳送至該泵驅動器的第二信號。The system of claim 2 or 3, wherein the controller is configured to receive the first signal from the RBC detection module and to generate a signal to be transmitted to the pump driver after receiving the first signal The second signal. 如請求項4的系統,其中該泵驅動器被配置成用以接收該第二信號,以及在接收該第二信號之後驅動該泵來停止將一流體從該第一容器移動至該泵。The system of claim 4, wherein the pump driver is configured to receive the second signal and to drive the pump to stop moving a fluid from the first container to the pump after receiving the second signal. 如請求項1至5之任一項的系統,其中該血液分離裝置進一步包含一溫度感測器被配置成用以偵測一位於該第一容器內之流體的溫度以及當該溫度被偵測到之時產生一要被傳送至該控制器的第三信號。The system of any one of claims 1 to 5, wherein the blood separation device further comprises a temperature sensor configured to detect a temperature of a fluid located in the first container and when the temperature is detected A third signal to be transmitted to the controller is generated. 如請求項6的系統,其中該血液分離裝置進一步包含一被耦合至該控制器的冷卻驅動器,以及其中該控制器被配置成在接收該第三信號之後產生並且傳送一第四信號至該冷卻驅動器。The system of claim 6, wherein the blood separation device further comprises a cooling driver coupled to the controller, and wherein the controller is configured to generate and transmit a fourth signal to the cooling after receiving the third signal driver. 如請求項7的系統,其中該冷卻驅動器被配置成用以接收該第四信號以及在接收該第四信號之後驅動冷卻模組以調節一位於該第一容器內的流體之溫度。The system of claim 7, wherein the cooling driver is configured to receive the fourth signal and to drive a cooling module to adjust a temperature of a fluid located within the first container after receiving the fourth signal. 如請求項1至8之任一項的系統,其中該分離裝置進一步包含一支持件被配置成用以按壓該第一容器抵靠著該冷卻模組。The system of any one of claims 1 to 8, wherein the separating device further comprises a support configured to press the first container against the cooling module. 如請求項1至9之任一項的系統,其中該分離裝置進一步包含一散熱座被調適為用以將熱從該冷卻模組傳送至該血液分離裝置的周圍。The system of any one of claims 1 to 9, wherein the separating device further comprises a heat sink adapted to transfer heat from the cooling module to the periphery of the blood separation device. 如請求項1至10之任一項的系統,其中該匣進一步包含一個第二容器與該泵呈流體流動連通,其中該泵被調適為用以將一流體從該泵移動至該第二容器。The system of any one of claims 1 to 10, wherein the crucible further comprises a second container in fluid flow communication with the pump, wherein the pump is adapted to move a fluid from the pump to the second container . 如請求項11的系統,其中該泵驅動器可被配置為,在接收一來自該控制器的驅動信號之後,驅動該泵俾以將一流體從該泵移動至該第二容器。The system of claim 11, wherein the pump driver is configurable to drive the pump to move a fluid from the pump to the second container after receiving a drive signal from the controller. 如請求項1至12之任一項的系統,其中該匣被調適為,當被定位於該血液分離裝置之內時,容許一位於該第一容器之內的血液樣品藉由重力而分離成為一上層與一下層。The system of any one of claims 1 to 12, wherein the sputum is adapted to allow a blood sample located within the first container to be separated by gravity when positioned within the blood separation device One upper layer and one lower layer. 如請求項1至13之任一項的系統,其中該泵和該第二容器這兩者被配置成要被可逆地附接至該匣。The system of any one of claims 1 to 13, wherein both the pump and the second container are configured to be reversibly attached to the crucible. 如請求項1至14之任一項的系統,其中該分離裝置被配置成經由無線通信來與一中央控制單元連通。The system of any one of claims 1 to 14, wherein the separating device is configured to communicate with a central control unit via wireless communication. 如請求項1至15之任一項的系統,其中該分離裝置被配置成用以將該匣可逆地鎖定在該分離裝置中。The system of any one of claims 1 to 15, wherein the separating device is configured to reversibly lock the file in the separating device. 一種用以分離一血液樣品的方法,其包括: 提供一包含下列的匣:(i)一個含有一被混合以一種二價陽離子螯合抗凝血劑的血液樣品之第一容器,其中該第一容器包含一第一開口;(ii)一與該第一開口呈流體流動連通的配管;(iii) 一與該配管呈流體流動連通的泵,其中該泵被可逆地附接至該匣而且被配置成用以將一流體從該第一容器移動至該泵以及用以保持一流體;以及(iv)一被安裝至該配管的止回閥,其中該止回閥被配置成用以容許一流體從該第一容器流動至該泵而且不容許一流體從該泵流動至該第一容器,其中該匣被配置成要被可逆地附接至一血液分離裝置; 將該匣附接至該血液分離裝置而使得該第一容器係處於一直立位置而且該第一開口係位在該容器的頂部; 將該第一容器之內的血液樣品冷卻至2℃和12℃; 將該血液樣品維持在2℃和12℃之下歷時6至72小時,藉此該血液樣品藉由重力而分離成為一上層與一下層;以及 將一部分的上層從該第一容器泵送通經該第一開口和該配管而至該泵直至位在該配管內的紅血球在一位處於該第一開口和該泵之間的偵測點之處被偵測到,其中該泵保持該部分的上層。A method for isolating a blood sample, comprising: providing a first container comprising: (i) a blood sample comprising a blood sample mixed with a divalent cation chelated anticoagulant, wherein the first a container comprising a first opening; (ii) a pipe in fluid flow communication with the first opening; (iii) a pump in fluid flow communication with the pipe, wherein the pump is reversibly attached to the port and Configuring to move a fluid from the first container to the pump and to hold a fluid; and (iv) a check valve mounted to the pipe, wherein the check valve is configured to allow a fluid flows from the first container to the pump and does not allow a fluid to flow from the pump to the first container, wherein the file is configured to be reversibly attached to a blood separation device; attaching the file to The blood separation device such that the first container is in an upright position and the first opening is in the top of the container; the blood sample in the first container is cooled to 2 ° C and 12 ° C; the blood sample is Maintained at 2 ° C and 12 ° C 6 to 72 hours, whereby the blood sample is separated into an upper layer and a lower layer by gravity; and a portion of the upper layer is pumped from the first container through the first opening and the pipe until the pump is in position The red blood cells in the tube are detected at a detection point between the first opening and the pump, wherein the pump holds the upper layer of the portion. 如請求項19的方法,其中該匣進一步包含一個第二容器與該泵呈流體流動連通,該方法進一步包括一個用以將位於該泵內之該部分的上層之一部分泵送至該第二容器的步驟,其中該第二容器保持該部分的上層之該部分。The method of claim 19, wherein the crucible further comprises a second container in fluid flow communication with the pump, the method further comprising pumping a portion of the upper layer of the portion of the pump to the second container a step wherein the second container holds the portion of the upper layer of the portion. 如請求項18的方法,進一步包括從該血液分離裝置移出該匣以及從該匣拆卸出該泵和該第二容器。The method of claim 18, further comprising removing the cartridge from the blood separation device and removing the pump and the second container from the cartridge. 如請求項17的方法,其中該血液分離裝置含有一紅血球(RBC)偵測模組以及一泵驅動器,其中該RBC偵測模組被配置成用以偵測位在該偵測點之處的該配管內的紅血球,以及該泵驅動器被配置成用以驅動該泵將一流體從該第一容器移動至該泵以及將一流體從該泵移動至該第二容器。The method of claim 17, wherein the blood separation device comprises a red blood cell (RBC) detection module and a pump driver, wherein the RBC detection module is configured to detect a position at the detection point The red blood cells within the tubing, and the pump driver are configured to drive the pump to move a fluid from the first container to the pump and to move a fluid from the pump to the second container. 一種血液分離裝置,其包括: 一控制器, 一冷卻模組被配置成用以冷卻一血液樣品, 一紅血球(RBC)偵測模組被配置成用以偵測一位在一偵測點之處的血液樣品內的紅血球以及如果紅血球被偵測到之時產生一第一信號,以及 一泵驅動器被配置成用以驅動一血液樣品流經該偵測點。A blood separation device comprising: a controller, a cooling module configured to cool a blood sample, and a red blood cell (RBC) detection module configured to detect a bit at a detection point The red blood cells in the blood sample and a first signal are generated if the red blood cells are detected, and a pump driver is configured to drive a blood sample through the detection point. 如請求項21的血液分離裝置,其中該控制器被配置成用以接收來自該RBC偵測模組的該第一信號,以及在接收該第一信號之後產生一要被傳送至該泵驅動器的第二信號。The blood separation device of claim 21, wherein the controller is configured to receive the first signal from the RBC detection module and to generate a signal to be transmitted to the pump driver after receiving the first signal The second signal. 如請求項21的血液分離裝置,進一步包括一支持件被配置成用以保持以及按壓一容器抵靠著該冷卻模組。The blood separation device of claim 21, further comprising a support member configured to hold and press a container against the cooling module. 如請求項21的血液分離裝置,其中該RBC偵測模組被配置成用以發射一光至該偵測點以及偵測明確地表示紅血球存在於流體中的該光之反射、散射、吸收或螢光。The blood separation device of claim 21, wherein the RBC detection module is configured to emit a light to the detection point and to detect a reflection, scattering, absorption or reflection of the light that clearly indicates that the red blood cell is present in the fluid Fluorescent. 如請求項21的血液分離裝置,進一步包括一含有該RBC偵測模組、該泵驅動器以及該冷卻模組的外殼,其中一位於該外殼之內的空間被配置成用以容置一要被可拆卸地鎖定至該血液分離裝置的匣。The blood separation device of claim 21, further comprising a housing including the RBC detection module, the pump driver, and the cooling module, wherein a space within the housing is configured to accommodate a to be Removably locked to the helium of the blood separation device. 一種被配置成要被定位於一如請求項21的血液分離裝置之內的匣,其包括: 一被配置成用以含有一血液樣品的第一容器,其中該匣被配置成要被定位於該血液分離裝置之內,而使得該第一容器在該血液分離裝置之內被保持處於一直立位置而且有一開口係位在該第一容器的頂部; 一與該開口呈流體流動連通的配管; 一與該配管呈流體流動連通的泵,其中該泵被配置成用以含有一流體;以及 一被安裝至該配管的止回閥,其中該止回閥被配置成用以容許一流體從該第一容器流動至該泵而且不容許一流體從該泵流動至該第一容器。A file configured to be positioned within a blood separation device as claimed in claim 21, comprising: a first container configured to contain a blood sample, wherein the file is configured to be positioned The blood separation device is such that the first container is held in an upright position within the blood separation device and has an opening at the top of the first container; a pipe in fluid flow communication with the opening; a pump in fluid flow communication with the pipe, wherein the pump is configured to contain a fluid; and a check valve mounted to the pipe, wherein the check valve is configured to allow a fluid from the The first container flows to the pump and does not allow a fluid to flow from the pump to the first container. 如請求項26的匣,進一步包括一與該泵呈流體流動連通的第二容器,其中該第二容器被配置成用以含有一從該泵流動至該第二容器的流體。The crucible of claim 26, further comprising a second container in fluid flow communication with the pump, wherein the second container is configured to contain a fluid flowing from the pump to the second container. 如請求項26的匣,進一步包括一被安裝置該配管的過濾器,其中該過濾器被配置成用以過濾來自一流經該配管的流體之白血球。The cartridge of claim 26, further comprising a filter mounted to the tubing, wherein the filter is configured to filter white blood cells from fluids that are first passed through the tubing.
TW106113638A 2016-04-22 2017-04-24 Blood separation system TW201742641A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662326168P 2016-04-22 2016-04-22

Publications (1)

Publication Number Publication Date
TW201742641A true TW201742641A (en) 2017-12-16

Family

ID=60116423

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106113638A TW201742641A (en) 2016-04-22 2017-04-24 Blood separation system

Country Status (5)

Country Link
EP (1) EP3445417A4 (en)
JP (1) JP2019514477A (en)
CN (1) CN109069709A (en)
TW (1) TW201742641A (en)
WO (1) WO2017184954A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175420B1 (en) * 1998-05-20 2001-01-16 Zymequest, Inc. Optical sensors for cell processing systems
US7011761B2 (en) * 1999-09-03 2006-03-14 Baxter International Inc. Red blood cell processing systems and methods which control red blood cell hematocrit
US20020020680A1 (en) * 2000-06-20 2002-02-21 Glen Jorgensen Blood component preparation (BCP) device and method of use thereof
US6790371B2 (en) * 2001-04-09 2004-09-14 Medtronic, Inc. System and method for automated separation of blood components
US6610002B2 (en) * 2001-04-09 2003-08-26 Medtronic, Inc. Method for handling blood sample to ensure blood components are isolated
US6890291B2 (en) * 2001-06-25 2005-05-10 Mission Medical, Inc. Integrated automatic blood collection and processing unit
US7264608B2 (en) * 2001-12-05 2007-09-04 Fenwal, Inc. Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
AU2002364550A1 (en) * 2001-12-10 2003-06-23 Gambro, Inc. Methods and apparatus for leukoreduction of red blood cells
JP2005523128A (en) * 2002-04-24 2005-08-04 インターポア・オルソペディックス Blood separation and concentration system
JP5223007B2 (en) * 2008-11-28 2013-06-26 テルモ株式会社 Blood bag system and cassette

Also Published As

Publication number Publication date
JP2019514477A (en) 2019-06-06
EP3445417A1 (en) 2019-02-27
EP3445417A4 (en) 2019-11-20
CN109069709A (en) 2018-12-21
WO2017184954A1 (en) 2017-10-26

Similar Documents

Publication Publication Date Title
JP2021178210A (en) Systems, devices and methods for bodily fluid sample collection, transport and handling
JP2625426B2 (en) Equipment for use with patient care equipment
JP2018505660A (en) Devices and methods for molecular diagnostic tests
US20120052485A1 (en) Sperm separation system
EP2131892B1 (en) Apparatus and methods for early stage peritonitis detection including self-cleaning effluent chamber
JP2017510258A (en) System for organizational operations
WO2007124448A2 (en) Method and apparatus for the management of diabetes
JP2021099372A (en) Systems, devices, and methods for bodily fluid sample collection, transport, and handling
US20210341360A1 (en) Diagnostic systems and methods
TW201617445A (en) Systems and methods for low power thermal cycling
US20060020227A1 (en) Collection means and a method for collecting cord blood
JP6739782B2 (en) Pretreatment kit for gene analysis, nucleic acid analysis chip, gene analysis system
TW201742641A (en) Blood separation system
US20150037305A1 (en) Systems, Methods, and Apparatus for Resuspending Cells from Surgical Laundry
JP7369715B2 (en) Automated isolation of viable mitochondria
KR20190042093A (en) Diagnostic System and Method
US20210311016A1 (en) Malaria species detection
JP7290345B2 (en) Genetic analysis pretreatment kit, nucleic acid analysis chip, analysis system, biomaterial analysis chip
EP3405102B1 (en) Apparatus for detecting cells in circulating bloodstream
JP2022502060A (en) In vitro fertilization system and related components
WO2019186547A1 (en) Follicular content storage
JP6982338B2 (en) Pretreatment kit for gene analysis, chip for nucleic acid analysis, analysis system, chip for biomaterial analysis
RU2482796C2 (en) Device for measuring, at least, one parameter of arterial blood sample
US20220146491A1 (en) Diagnostic testing devices, systems and methods
US20210346590A1 (en) Analytical method for controlled and measured internal fluid after surgery